BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND SFPQ, PSF, 6421, ENSG00000116560, P23246 AND Staging
3 results:

  • 1. Influence of PET reconstruction technique and matrix size on qualitative and quantitative assessment of lung lesions on [18F]-FDG-PET: A prospective study in 37 cancer patients.
    Riegler G; Karanikas G; Rausch I; Hirtl A; El-Rabadi K; Marik W; Pivec C; Weber M; Prosch H; Mayerhoefer M
    Eur J Radiol; 2017 May; 90():20-26. PubMed ID: 28583635
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Relative role of motion and psf compensation in whole-body oncologic PET-MR imaging.
    Petibon Y; Huang C; Ouyang J; Reese TG; Li Q; Syrkina A; Chen YL; El Fakhri G
    Med Phys; 2014 Apr; 41(4):042503. PubMed ID: 24694156
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
    Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Bardet S; Gervais R; Lemoel G; Zalcman G; Aide N
    Clin Nucl Med; 2012 Oct; 37(10):971-6. PubMed ID: 22899197
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.